TRAnexamic acid in hemorrhagic CESarean section (TRACES) randomized placebo controlled dose-ranging pharmacobiological ancillary trial: study protocol for a randomized controlled trial
Abstract Background Evidence increases that a high or a standard dose of tranexamic acid (TA) reduces postpartum bleeding. The TRACES pharmacobiological substudy aims to establish a therapeutic strategy in hemorrhagic (H) Cesarean section (CS) with respect to the intensity of fibrinolysis by using i...
Main Authors: | Anne-Sophie Ducloy-Bouthors, Emmanuelle Jeanpierre, Imen Saidi, Anne-Sophie Baptiste, Elodie Simon, Damien Lannoy, Alain Duhamel, Delphine Allorge, Sophie Susen, Benjamin Hennart |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-03-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-017-2421-6 |
Similar Items
-
Therapeutic and pharmaco-biological, dose-ranging multicentre trial to determine the optimal dose of TRAnexamic acid to reduce blood loss in haemorrhagic CESarean delivery (TRACES): study protocol for a randomised, double-blind, placebo-controlled trial
by: Anne-Sophie Bouthors, et al.
Published: (2018-03-01) -
Pharmacokinetics of Curative Tranexamic Acid in Parturients Undergoing Cesarean Delivery
by: Sixtine Gilliot, et al.
Published: (2022-03-01) -
Assessing Plasmin Generation in Health and Disease
by: Adam Miszta, et al.
Published: (2021-03-01) -
Tranexamic acid for haemostasis and beyond: does dose matter?
by: Tammy Lam, et al.
Published: (2023-09-01) -
CALIX[4]ARENES METHYLENE BISPHOSPHONIC ACIDS EFFECT ON PLASMIN ACTIVITY
by: O. I. Yusova, et al.
Published: (2018-10-01)